ASX Announcement

First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS

Published: 06/05/20, 10:13am (AEST)2 pages
Mesoblast Limited
MSB:ASXHealthcare

Recent MSB Announcements

Price Sensitive only